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Abstract
Background/Objectives—Melanocortins play a crucial role in appetite and weight regulation. 
Although the melanocortin 4 receptor (MC4R) gene has been repeatedly linked to obesity and 
antipsychotic-induced weight gain, the mechanism behind how it leads to this effect in still 
undetermined. The goal of this study was to conduct an in-depth and sophisticated analysis of 
MC4R polymorphisms, body mass index (BMI), eating behaviour, and depressed mood.
Subjects/Methods—We genotyped 328 individuals of European ancestry on the following 
MC4R markers based on the relevant literature on obesity and antipsychotic-induced weight gain: 
rs571312, rs17782313, rs489693, rs11872992, and rs8087522. Height and weight were measured, 
and information on depressed mood and overeating behaviours was obtained during the in-person 
assessment.
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Results—BMI was associated with rs17782313 C allele; however this finding did not survive 
correction for multiple testing (p=0.018). Although rs17782313 was significantly associated with 
depressed mood and overeating behaviours, tests of indirect effects indicated that emotional eating 
and food cravings, rather than depressed mood, uniquely accounted for the effect of this marker 
and BMI (n=152).
Conclusions—To our knowledge, this is the first study to investigate the link between MC4R 
rs17782313, mood and overeating behaviour, as well as to demonstrate possible mechanisms 
behind MC4R’s influence on body weight. If replicated in a larger sample, these results may have 
important clinical implications, including potential for the use of MC4R agonists in the treatment 
of obesity and disordered eating.
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INTRODUCTION
It is estimated that one billion adults worldwide are overweight or obese (1). The causes of 
obesity are complex, with biological, psychological, and environmental factors contributing 
to its etiology. Various hormones and neurotransmitter systems have been studied in relation 
to appetite and weight regulation in the hope of shedding light on the biological risk factors 
for overeating and obesity (2–4).
Melanocortins are expressed in the hypothalamus and play an important role in regulating 
appetite. Stimulation of brain melanocortin results in a decrease in food intake and weight; 
similarly, mutations and defects of the melanocortin 4 receptor (MC4R) gene have been 
implicated in animal models and human studies of weight gain (5–7). Genome-wide 
association studies (GWAS) and meta-analyses of GWAS suggest that several markers near 
MC4R (e.g., rs17782313, rs571312) are strongly associated with obesity in healthy adults, 
adolescents, and children (8–13). There have also been small- and large-scale candidate 
gene studies that replicated the GWAS findings on MC4R in various ancestral populations 
and age groups (14–16). More recently, a GWAS on second-generation antipsychotic-
induced weight gain found a peak at MC4R on chromosome 18, and an association with 
rs489693 (17). Similarly, rs8087522, identified as a putative transcription factor-binding site 
in the promoter region of the MC4R gene, has been implicated in weight gain following the 
prescription of antipsychotic medications (18).
Although it is well documented that common variants near MC4R are associated with an 
increased susceptibility for gaining weight, the mechanisms behind this effect are not fully 
understood. Animal studies have demonstrated that MC4R deficiency may be responsible 
for various metabolic and eating-related changes such as increased feeding (19) and high-fat 
hyperphagia (7). It is not clear, however, whether these models apply to the near MC4R 
region, which is often not covered in animal knockout models. MC4R rs17782313, located 
downstream of the MC4R gene, has been studied extensively and replicated consistently in 
its relation to weight gain (8–16). Thus far, rs17782313 has not been linked to micro- or 
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macro-nutrient intake (20, 21). In two preliminary studies of obese Chilean children, 
however, rs17782313 C homozygosity was associated with increased food-enjoyment scores 
and sweet snack consumption (22, 23). In summary, despite the well-established link 
between MC4R common variants and body weight, no clear mechanism of action has been 
found to explain how these variants are associated with weight gain in the general 
population.
MC4R is also known to interact with the serotonin and dopamine pathways, thereby 
suggesting a possible involvement of MC4R in mood regulation. The relationship between 
melanocortins and serotonin has been well documented (24), and the effects of the 
antidepressant d-fenfluramine (a serotonin receptor 2C agonist) are significantly diminished 
in Mc4r knockout mice (25). At the molecular level, it has been recently demonstrated that 
MC4R signaling may be involved in triggering stress-induced synaptic adaptations in the 
nucleus accumbens, an area of the brain associated with reward processing and where 
dopamine is highly expressed (26). Furthermore, blocking MC4R signaling in this region 
has reversed anhedonia in rodents (26), demonstrating the possible link between dysphoria 
and melanocortins. Despite the evidence for a possible role of the melanocortin system in 
mood regulation, to date, no study has investigated whether there are links between MC4R 
genetic variants and depressed mood nor explored how depressed mood, may affect eating 
behaviour or BMI in the presence of MC4R genetic risk variants. One possibility is that 
MC4R predisposes individuals to weight gain via two related pathways: 1) via overeating 
behaviours and 2) via depressed mood.
The objectives of the current study were: 1) to examine the relationship between MC4R 
markers and BMI; and 2) to investigate associations between MC4R common variants and 
eating behaviours associated with over-consumption (viz. emotional eating, binge eating, 
food cravings, and hedonically-driven eating); and 3) to assess overeating behaviours and 




Adults between the ages of 24 and 50 years (230 women and 98 men) were recruited 
through advertisements placed at universities, hospitals, other public institutions, and local 
newspapers in the Greater Toronto Area, as well as online sites such as Craigslist. All 
participants were of European ancestry. Exclusion criteria included: 1) not being fluent in 
English or having lived in North America for less than five years; 2) being post-menopausal 
or having a pregnancy within the previous six months for female participants; 3) a current or 
lifetime DSM-IV-TR diagnosis of any psychotic disorder, alcohol/substance abuse or 
dependence; or 4) diagnosis of a serious medical/physical illness such as cancer, heart 
disease, or paralysis. Current or past diagnosis or treatment of other psychiatric disorders did 
not lead to exclusion from study participation. Prior to the in-person assessment, all 
participants were screened over the phone by the research coordinator to confirm basic 
eligibility criteria.
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All aspects of this research study were reviewed and approved by the Centre for Addiction 
and Mental Health Research Ethics Board and conducted in accordance with the Helsinki 
Declaration as revised in 1989.
Clinical measures
BMI (weight in kilograms/height in metres2) was calculated from measured height and 
weight obtained during the in-person screen.
Depressed Mood was assessed using the Beck Depression Inventory (BDI) (27). BDI, 
which consists of 21 items covering the one-week time period before the assessment, is one 
of the most commonly used scales for the evaluation of mood in clinical and research 
settings. It captures a variety of depressive symptoms such as dysphoria, changes in eating 
patterns, sleep disturbances, and anhedonia. Cronbach’s α coefficient in the present study 
was 0.94.
Binge Eating was assessed by the five-item subscale of the Binge Eating Questionnaire 
(BEQ) (28), which includes frequency and severity of symptoms such as loss of control over 
eating, and negative affect following a binge. Cronbach’s α coefficient was 0.85.
Hedonically-Driven Eating was assessed by the Power of Food Scale (PFS) (29), a 21-item 
self-report questionnaire that assesses individual differences in the appetitive responsiveness 
to food independent of actual consumption (thus differentiating the motivation and 
appetitive drive for palatable foods from the tendency to overeat). Cronbach’s α coefficient 
was 0.97.
Emotional Eating was assessed by two separate questionnaires: i) the same-named subscale 
of the Dutch Eating Behaviour Questionnaire (DEBQ) (30), which reflects the degree to 
which eating behaviour is triggered by emotional states such as worry rather than by hunger 
(e.g., “Do you have the desire to eat when somebody lets you down?”); and ii) the Eating 
Behaviour Patterns Questionnaire (EBPQ) (31). Similar to the DEBQ, the EBPQ emotional-
eating subscale captures eating driven by emotional states as opposed to internal hunger cues 
(e.g., “When I am in a bad mood, I eat whatever I feel like eating.”). Cronbach’s α 
coefficients for the two scales were 0.96 and 0.90, respectively.
Food Cravings were assessed by the Food Craving Questionnaire - Trait (FCQ-T) (32). 
This 39-item questionnaire derives from the evidence that food cravings can be expressed 
both physiologically and psychologically. The nine factor-analytically derived scales 
measure cravings experienced as, or associated with positive reinforcement, negative 
reinforcement, cue-dependent eating, feelings of hunger, preoccupation with food, intentions 
to eat, lack of control, negative affect, and guilty feelings. Cronbach’s α coefficient was 
0.98.
Snacking on Sweets was assessed with another subscale of the EBPQ, which reflects the 
extent to which the individual prefers foods with high-sugar content (e.g., “To me, cookies 
are an ideal snack food.”). Other subscales of EBPQ were not included in our analysis, 
because they are not relevant to overeating. Cronbach’s α coefficient was 0.77.
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Blood samples for genetic analysis were collected on the day of clinical assessment. Blood 
lymphocyte DNA was extracted using the high-salt method (33). The four MC4R single 
nucleotide polymorphisms (SNPs) genotyped as a part of this study (Table 1) were selected 
based on the literature on obesity and antipsychotic weight gain (8, 17, 18) and these 
markers and their context sequence information for the ABI assays (available on demand) 
are as follows: GTTTAAAGCAGGAGAGATTGTATCC[C/
T]GATGGAAATGACAAGAAAAGCTTCA for rs17782313 (ABI assay ID: 
C__32667060_10), TCTTAATTCTGTTGTCATTAGTTCC[A/C]G 
TTTGTTAAATGTTTACAGCGTGGC for rs489693 (ABI assay ID: C___3058718_10), 
TAAGAACCCAGCCAGTAGTGGTTCA[A/G]TTAAAATACCTGAAAAACAGAGAGG 
for rs8087522 (ABI assay ID: C__29004626_10), and 
ATTATGAATGGGTTCAAAAGGGGTT [A/G]ATTTTAATGCACTAATATCCCATAT 
for rs11872992 (ABI assay ID: C___2747891_10). Due to having been associated with BMI 
in a number of important publications (10), we also included MC4R rs571312 in our study. 
However, because it is well documented that rs571312 is in high linkage disequilibrium 
(LD) with rs17782313, we decided to analyze this SNP in a post hoc manner, separate from 
the other four SNPs. The context sequence information for the ABI assay (available on 
demand) for rs571312 is AAATTTGAGT TGCAGCTTTAAGTGA[A/
C]CTATGACCCGATGTTTGTGTAAAAT (ABI assay ID: C____797201_10). Polymerase 
chain reactions of 10μl volume using 20 ng genomic DNA were performed using Assays-on-
Demand by Applied Biosystems Inc. (ABI; Carlsbad, CA) under the following conditions: 
95°C for 10 min, followed by 60 cycles of 92°C 15 s, 60°C 1 min. Determination of alleles 
was performed using the ABI 7500 Sequence Detection System with the Allelic 
Discrimination software. Genotyping of the DNA was performed at the Neurogenetics 
Laboratory at the Centre for Addiction and Mental Health in Toronto, Canada, with 
laboratory staff blind to psychiatric diagnosis. For quality control purposes, 10% of the 
samples were re-genotyped, and ambiguous genotypes were excluded from the analysis.
Statistical Methods
Hardy-Weinberg equilibrium and LD were assessed using a chi-squared test through 
Haploview version 4.0. The relationships between MC4R genotypes and BMI measures 
were assessed using linear regression in SPSS 15.0 (genotype coded as 0 for TT, 1 for CT 
and 2 for CC), whereas UNPHASED version 3.1.5 was used to perform allelic analysis. For 
the quantitative analyses involving BMI, we corrected for multiple testing using Single 
Nucleotide Polymorphism Spectral Decomposition (SNPSpD; 34), determining the effective 
number of independent marker loci to be 3, thus setting the significance threshold α at 
0.017.
Tests of mediation (also known as tests of indirect effects) are a common statistical 
approach in psychological science to test hypothesized processes (such as eating behaviours) 
linking distal variables (such as genetic vulnerability) and more proximal outcomes (such as 
weight). Originally based on the work of Baron and Kenny (35), tests of mediation assess 
whether putative mediating variables account for the association between a predictor 
variable and the outcome variable. More recent approaches assess whether the cross-product 
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of path coefficient linking the predictor variable and the mediating variable (path a) and the 
path coefficient linking the mediating variable and the outcome variable (path b) is 
significantly different from zero. This approach uses bootstrapping to create 95% confidence 
intervals around the “true” value of this cross-product (referred to as the indirect effect). If 
zero is not within this confidence interval then the indirect (i.e., mediating) effect if 
significant. This approach can be extended to assess multiple mediators simultaneously. 
Multiple mediation analyses assess the significance of the indirect pathways via putative 
mediators as well as the overall mediation model. In order to test simultaneously whether the 
overeating behaviours and depressed mood accounted for the association between MC4R 
(coded for the number of risk alleles present carried by an individual) and BMI, a multiple 
mediation model was tested according to the procedures described by Preacher and Hayes 
(36). As shown in Figure 1, path c refers to the total effect of MC4R on BMI in the absence 
of the mediators. Specific indirect effects refer to the influence of path a x path b via each 
specific mediator (a1 x b1 is the indirect effect of MC4R on BMI via depressed mood; a2 x 
b2 is the indirect effect of MC4R on BMI via overeating behaviours). Multiple mediation 
analysis also allows statistical control over the correlations between the mediators. The total 
indirect effect reflects the summation of the specific indirect effects. Path c′ refers to the 
direct effect of MC4R on BMI when also controlling for the mediators.
Bias-corrected bootstrap confidence intervals (n=5000, confidence intervals set at 95%) 
were used to assess the significance of indirect effects. The SPSS “INDIRECT” macro 
developed to accompany the paper by Preacher and Hayes (36) was used to test the 
significance of the overall total indirect effect, as well as the significance of the specific 
individual mediators. The absence of zero in the confidence interval indicates significant 
indirect (i.e., mediated) effects.
RESULTS
Sample Description
Table 2 summarizes the genetic baseline characteristics of the participants included in the 
study. Minor allele frequencies for the MC4R loci in our sample were as follows: 23.3% for 
rs571312, 24.1% for rs17782313 (n=322), 31.9% for rs489693 (n=324), 30.3% for 
rs8087522 (n=322), and 15.3% for rs11872992 (n=323). The average rate for successful 
genotyping across the SNPs was over 98%, and all markers were in Hardy-Weinberg 
equilibrium. LD plot for the study sample is shown in Figure 2.
The Association between MC4R Loci and BMI
Table 3 summarizes the relationship between the MC4R common variants and BMI. In 
accord with previous studies (8–13), carriers of the rs17782313 minor allele had a higher 
BMI compared to carriers of the major allele. After correction for multiple testing, however, 
this finding was a strong trend that closely approached statistical significance (p=0.018). 
Genotypic analysis revealed a dominant effect for the C allele, but this finding also fell short 
of statistical significance after correcting for multiple testing (p=0.028). The other three 
MC4R markers were not associated with BMI in our sample.
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MC4R rs571312 was analyzed separately from the other SNPs in a post hoc manner because 
it was in high LD with rs17782313. The association of rs571312 with BMI also did not 
reach significance following correction (p=0.054 for allelic analysis; n=321; results not 
shown).
Associations among rs17782313, Overeating Behaviours, and Depressed Mood
The rs17782313 C allele was significantly associated with elevated scores on the DEBQ 
Emotional Eating subscale (r=0.17, p=0.004), the EBPQ Emotional Eating subscale (r=0.15, 
p=0.01), and the FCQ-T (r=0.20, p=0.013). None of the other MC4R markers were related to 
scores on any of the other overeating measures. The C allele of the rs17782313 
polymorphism was also significantly associated with an increase in depressed mood, as 
assessed using the BDI (r=0.18, p=0.005). BDI and BMI were highly correlated (r=0.33, 
p<0.001); similarly, BDI was significantly associated with the DEBQ Emotional Eating 
subscale (r=0.54, p<0.001), the EBPQ Emotional Eating subscale (r=0.50, p<0.001), and the 
FCQ-T (r=0.54, p<0.001). Due to the significant associations of rs17782313 with overeating 
behaviour and depressed mood, mediation analyses were carried out to test the indirect 
effect of the MC4R marker on BMI, with depressed mood, and the overeating measures 
significantly associated with this marker (viz. the two emotional-eating variables and food 
cravings) as the mediators.
Mediation Analyses
Only 152 participants completed all measures used in the mediation analyses. The three 
overeating variables were highly correlated and appear to be measuring a shared construct. 
One strategy for managing highly correlated variables is to calculate a factor score to 
capture their shared variance. This approach resolves the problems associated with multi-
collinearity and increases scale reliability (37). Thus, an exploratory factor analysis was 
carried out to create a single composite score of the emotional-eating and craving variables.1 
A single factor accounted for 86% of variance in the three overeating scales and all three 
loaded strongly on the factor (loadings ranging between 0.925 and 0.931).
As shown in Figure 1, the total indirect effect was statistically significant (unstandardized 
coefficient = 1.61; 95% CI: 0.52 – 3.03). However, only the overeating factor produced a 
significant specific indirect effect (Unstandardized coefficient = 1.31; 95% CI: 0.38 – 2.69) 
after controlling for depressed mood. While depressed mood was significantly associated 
with MC4R and BMI, the specific indirect effect was not significant (unstandardized 
coefficient = 0.31; 95% CI: −0.21 – 1.25). Therefore, whilst MC4R rs17782313 is associated 
with both depressed mood and emotional eating/cravings, only the latter shows a unique 
indirect effect to BMI (when controlling for depressed mood).2
1Data for this study were collected over a period of six years, and the FCQ was added as a measure about halfway through the data 
collection. Our exploratory analyses showed that the group with the FCQ scores was on average had a higher BMI than the group 
without the FCQ scores. The reason for this difference was that as the study progressed, the recruitment focus shifted to including 
individuals who were overweight, as this group gave us a greater spread of scores on our measures of overeating. To account for the 
missing data on the Food Cravings and emotional eating scales used in our study, data were imputed using Expectation Maximization 
Imputation and the model tested again (n = 322). Equivalent results were found with the imputed data with the total indirect effect 
(1.43; 95% CI: 0.57–2.29) and the specific indirect effect via eating (1.14; 95% CI: 0.44 – 1.93) significantly different from zero. The 
specific indirect effect via depressed mood remained non-significant (.28; 95% CI: −0.03 –0.85).
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To date, little is known about the mechanisms by which MC4R common variants contribute 
to high BMI, and only a few studies have investigated the role of eating behaviour in this 
association. Furthermore, despite the interconnections among the melanocortinergic, 
dopaminergic and serotonergic systems, MC4R-linked obesity has not been studied in 
relation to depressed mood. This project is the first to propose a possible mechanism to 
explain the relationship between MC4R rs17782313 and BMI. Specifically, we hypothesized 
two pathways by which MC4R may increase body weight: 1) via depressed mood and 2) via 
overeating behaviours. As discussed in the Results section, the rs17782313 polymorphism 
was associated with both depressed mood and emotional eating/cravings. However, when 
accounting for the shared variance between emotional eating and depressed mood, our 
analysis revealed that eating behavior alone (more specifically emotional eating and food 
cravings) accounted for the association between rs17782313 and BMI in our sample.
To our knowledge, the indirect effect of MC4R rs17782313 on BMI via emotional eating 
and food cravings is a novel pathway that has neither been proposed nor demonstrated 
before. The result of our mediation analysis is especially intriguing in that a causal link 
between depression/anhedonia and overeating has been well documented. One of the 
diagnostic criteria for major depressive disorder is a change in eating behaviour, and 
individuals suffering from atypical depression or seasonal affective disorder often present 
with overeating (38). Furthermore, patients with atypical depression—especially women—
are more likely to be obese and present with higher BMI, waist-to-hip ratio, and percent fat 
mass compared to those with melancholic depression (39, 40). Although MC4R rs17782313 
was associated with depressed mood in our study, current evidence does not suggest a 
specific indirect role for depressed mood in increased BMI in individuals carrying the risk 
allele. Considering the well-documented link between overeating and disinhibition (41–45) 
and in line with the recent findings published by Horstmann and colleagues (46) regarding 
the genotype-related gray matter volume differences in the prefrontal cortex, our results 
suggest a possible role for disinhibition and impulsivity rather than anhedonia with regards 
to MC4R-linked weight gain.
It is also important to mention that in accord with previous findings (8–13), we detected a 
positive trend between rs17782313 and BMI. None of the markers associated with 
antipsychotic-induced weight gain (rs8087522 and rs489693) were related to BMI in our 
sample, suggesting that a different genetic mechanism may be responsible for medication-
induced changes in appetite. As we discussed, it was proposed that MC4R variants may 
affect body mass via more proximal factors such as overeating. In particular, our preliminary 
results suggest a potential pathway to high BMI via emotionally-driven eating and the 
presence of the MC4R rs17782313 risk allele. Although our significant pathway did not 
involve depressed mood, our results suggest that the C allele of the rs17782313 
polymorphism may play a role in the susceptibility to depression. We are unaware of any 
studies linking depression to MC4R variants in humans; however, recent animal studies have 
2The same models were also tested using the individual eating scales as the mediator of MC4R and BMI and showed equivalent 
results as the factor score.
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shown that disruption of MC4R negates the effects of antidepressant medications (25) and 
that MC4R may be associated with anhedonia (26). The functionality of the near-MC4R 
region (which includes rs17782313) is currently not well understood, and preclinical studies 
are needed to investigate the biological mechanism underlying the links between MC4R 
common variants and depressed mood.
In summary, while the rs17782313 was the only polymorphism associated with BMI, it was 
also the only SNP related to overeating behaviours. Specifically, rs17782313 C allele was 
associated with increased emotional eating and food cravings. This particular polymorphism 
has been previously associated with increased food enjoyment and snacking on sweets (22, 
23). In our study, however, the Snacking-on-Sweets measure was not linked to MC4R 
variants, which meshes with a recent report showing that Mc4r knockout mice increase their 
overall level of food consumption without an increased preference for high-fat or high-sugar 
foods (47). A recently published imaging study has also provided preliminary evidence for 
MC4R’s involvement with emotional eating (46), also in line with the findings of the present 
study.
Despite our novel findings, it is important to acknowledge some limitations of the current 
study. First, information on eating behaviours was obtained entirely from self-report 
measures. Therefore, since we did not include more objective measures from laboratory or 
observational paradigms, we must acknowledge the possibility of response bias. We also did 
not have complete data on the eating measures for all individuals included in the genetic 
analyses. In addition, the majority of our sample was women, and there have been numerous 
studies reporting sex differences for the effect of rs17782313 on various measures of food 
intake and body composition (20, 46, 48). However, when controlling for sex in the 
mediation analyses, there was minimal change to our results, suggesting that the association 
we identified may not be sex-biased. Finally, we anticipate that these preliminary findings 
will assist other researchers with hypothesis generation for future studies with larger 
samples.
If replicated, our preliminary results have a number of possible clinical implications. First, 
MC4R’s association with emotional eating and food cravings in our sample may suggest an 
MC4R-dopamine system interaction, especially considering that dopamine is highly 
expressed in the brain’s reward pathways and the involvement of dopaminergic genes in 
overeating has been widely reported (49–52). Our group has also demonstrated a link 
between markers of the dopamine receptor D2 (DRD2) gene and emotional eating in binge 
eating disorder (53). Administration of agouti related protein, a melanocortin inverse 
agonist, is known to activate the dopaminergic neurons in the midbrain, to increase 
dopamine turnover in the prefrontal cortex, and to attenuate sucrose-seeking behaviour in 
rats (54), highlighting the possible link between MC4R, dopamine, and eating behaviour. 
Furthermore, MC4R signaling of dopamine 1 receptor neurons has been shown to play a role 
in procedural memory learning (55), as well as in stress-induced synaptic adaptations in the 
nucleus accumbens (26), thus suggesting an interaction between the dopamine (specifically 
DRD1) and the melanocortin systems in mood regulation.
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The serotonin system also plays a pivotal role in the regulation of eating and mood, and the 
interaction between MC4R and serotonergic system on energy balance has been well 
documented (56, 57). As a result of this, a possible genetic interaction between the serotonin 
system genes and MC4R may also be responsible for our findings in eating behaviour, 
highlighting the possibility of utilizing serotonin agonists in the treatment of MC4R-linked 
obesity. For instance, MC4R agonists (such as BIM-22493, BIM-22511) (58) may be 
helpful in the treatment of a subgroup of obese individuals with increased emotional eating 
and food cravings.
In conclusion, our results suggest that increased emotional eating and food cravings may 
account for the association between MC4R rs17782313 and BMI. Furthermore, although 
rs17782313 was also linked to depressed mood in our sample, the effect of this 
polymorphism on BMI was not via depression. If replicated, this proposed mechanism has 
the potential to have significant impact on our understanding of MC4R-linked weight gain 
and obesity.
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Multiple mediation model of the relationship between MC4R, depressed mood, emotional 
eating/cravings, and BMI.
Note. Standardized coefficients are presented and tested for significance with 95% 
confidence intervals calculated using the bias-corrected bootstrap method (5000 samples). a 
= standardized IV to Med coefficient, b = standardized Med to DV coefficient, c = 
standardized total effect (IV to DV), c′ = standardized direct effect. Subscripts refer to 
specific indirect paths.
* p < .05
** p < .01
*** p <.001
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Linkage disequilibrium plot for the five MC4R markers.
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Table 1
MC4R marker information
MC4R marker Region Nucleotide substitution Minor allele
rs17782313 Near MC4R C/T C
rs489693 Near MC4R A/C A
rs8087522 MC4R promoter A/G A
rs11872992 MC4R promoter A/G A
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Table 2
Means and standard deviations (SD) for all quantitative variables in the study
Mean SD N
Age (years) 33.9 7.0 328
BMI (kg/m2) 31.8 9.5 327
BDI 10.6 9.6 250
BEQ 2.1 1.9 281
PFS 58.2 21.4 284
DEBQ_Emot 3.0 1.1 283
EBPQ_Emot 36.0 8.4 284
EBPQ_Sweet 17.5 4.9 284
FCQ-T 123.3 40.7 155
Note. BMI=Body Mass Index; BDI=Beck Depression Inventory; BEQ=Binge Eating Questionnaire; PFS = Power of Food Scale; 
DEBQ_Emot=Dutch Eating Behavior Questionnaire Emotional Eating subscale; EBPQ_Emot=Eating Behavior Patterns Questionnaire Emotional 
Eating subscale; EBPQ_Sweet=Eating Behavior Patterns Questionnaire Snacking on Sweets subscale; FCQ-T= Food Craving Questionnaire –
Trait.
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